...
search icon
acet-img

Adicet Bio Inc Share Price

ACET
NAQ
$7.06
+$0.02
(0.28%)
1D
Industry: Health Care Providers & Services Sector: Health Care

Adicet Bio Inc Analyst Forecast

Adicet Bio Inc Share Price Chart

Adicet Bio Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$67.58M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
259.54K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.56
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.41 L
$17.44 H
$7.06

About Adicet Bio Inc, Common Stock

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts. more

Industry: Health Care Providers & ServicesSector: Health Care

Adicet Bio Inc Stock Returns

Time FrameACETSectorS&P500
1-Week Return3.38%0.72%-1.31%
1-Month Return-10.89%1.27%0.78%
3-Month Return-26.81%3.13%3.46%
6-Month Return-39.31%15.81%6.19%
1-Year Return-54.64%8.89%11.68%
3-Year Return-94.39%20.79%71.21%
5-Year Return-97.22%35.89%74.81%
10-Year Return-99.63%138.44%256.59%

Adicet Bio Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue17.90M9.73M24.99M--[{"date":"2020-12-31","value":71.64,"profit":true},{"date":"2021-12-31","value":38.94,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue--5.01M6.10M6.47M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":77.44,"profit":true},{"date":"2023-12-31","value":94.28,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit17.90M9.73M24.99M(6.10M)(6.47M)[{"date":"2020-12-31","value":71.64,"profit":true},{"date":"2021-12-31","value":38.94,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-24.4,"profit":false},{"date":"2024-12-31","value":-25.88,"profit":false}]
Gross Margin100.00%100.00%100.00%--[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses57.09M71.16M97.54M152.04M127.61M[{"date":"2020-12-31","value":37.55,"profit":true},{"date":"2021-12-31","value":46.81,"profit":true},{"date":"2022-12-31","value":64.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":83.94,"profit":true}]
Operating Income(39.19M)(61.43M)(72.55M)(152.04M)(127.61M)[{"date":"2020-12-31","value":-3919100000,"profit":false},{"date":"2021-12-31","value":-6143300000,"profit":false},{"date":"2022-12-31","value":-7255100000,"profit":false},{"date":"2023-12-31","value":-15203800000,"profit":false},{"date":"2024-12-31","value":-12761500000,"profit":false}]
Total Non-Operating Income/Expense349.00K(776.00K)6.44M19.33M21.20M[{"date":"2020-12-31","value":1.65,"profit":true},{"date":"2021-12-31","value":-3.66,"profit":false},{"date":"2022-12-31","value":30.38,"profit":true},{"date":"2023-12-31","value":91.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(39.49M)(62.12M)(69.79M)(142.66M)(117.12M)[{"date":"2020-12-31","value":-3949300000,"profit":false},{"date":"2021-12-31","value":-6212400000,"profit":false},{"date":"2022-12-31","value":-6979000000,"profit":false},{"date":"2023-12-31","value":-14265800000,"profit":false},{"date":"2024-12-31","value":-11712200000,"profit":false}]
Income Taxes(2.81M)(125.00K)(2.76M)5.93M-[{"date":"2020-12-31","value":-47.47,"profit":false},{"date":"2021-12-31","value":-2.11,"profit":false},{"date":"2022-12-31","value":-46.56,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(36.68M)(62.00M)(67.03M)(148.59M)-[{"date":"2020-12-31","value":-3667800000,"profit":false},{"date":"2021-12-31","value":-6199900000,"profit":false},{"date":"2022-12-31","value":-6702900000,"profit":false},{"date":"2023-12-31","value":-14858810500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(36.68M)(62.00M)(69.79M)(142.66M)(117.12M)[{"date":"2020-12-31","value":-3667800000,"profit":false},{"date":"2021-12-31","value":-6199900000,"profit":false},{"date":"2022-12-31","value":-6979000000,"profit":false},{"date":"2023-12-31","value":-14265800000,"profit":false},{"date":"2024-12-31","value":-11712200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(36.68M)(62.00M)(69.79M)(142.66M)(117.12M)[{"date":"2020-12-31","value":-3667800000,"profit":false},{"date":"2021-12-31","value":-6199900000,"profit":false},{"date":"2022-12-31","value":-6979000000,"profit":false},{"date":"2023-12-31","value":-14265800000,"profit":false},{"date":"2024-12-31","value":-11712200000,"profit":false}]
EPS (Diluted)(5.68)(2.07)(1.71)(3.32)(1.34)[{"date":"2020-12-31","value":-568,"profit":false},{"date":"2021-12-31","value":-207,"profit":false},{"date":"2022-12-31","value":-171,"profit":false},{"date":"2023-12-31","value":-332,"profit":false},{"date":"2024-12-31","value":-133.99,"profit":false}]

Adicet Bio Inc Ratios

Adicet Bio Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ACET
Cash Ratio 5.44
Current Ratio 5.62

Adicet Bio Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ACET
ROA (LTM) -39.13%
ROE (LTM) -71.73%

Adicet Bio Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ACET
Debt Ratio Lower is generally better. Negative is bad. 0.22
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.78

Adicet Bio Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ACET
Trailing PE NM
Forward PE NM
P/S (TTM) 9.72
P/B 0.61
Price/FCF NM
EV/R 2.14
EV/Ebitda NM
PEG 0.82

FAQs

What is Adicet Bio Inc share price today?

Adicet Bio Inc (ACET) share price today is $7.06

Can Indians buy Adicet Bio Inc shares?

Yes, Indians can buy shares of Adicet Bio Inc (ACET) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ACET stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Adicet Bio Inc be purchased?

Yes, you can purchase fractional shares of Adicet Bio Inc (ACET) via the Vested app. You can start investing in Adicet Bio Inc (ACET) with a minimum investment of $1.

How to invest in Adicet Bio Inc shares from India?

You can invest in shares of Adicet Bio Inc (ACET) via Vested in three simple steps:

  • Click on Sign Up or Invest in ACET stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Adicet Bio Inc shares
What is Adicet Bio Inc 52-week high and low stock price?

The 52-week high price of Adicet Bio Inc (ACET) is $17.44. The 52-week low price of Adicet Bio Inc (ACET) is $6.41.

What is Adicet Bio Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Adicet Bio Inc (ACET) is

What is Adicet Bio Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Adicet Bio Inc (ACET) is 0.61

What is Adicet Bio Inc dividend yield?

The dividend yield of Adicet Bio Inc (ACET) is 0.00%

What is the Market Cap of Adicet Bio Inc?

The market capitalization of Adicet Bio Inc (ACET) is $67.58M

What is Adicet Bio Inc's stock symbol?

The stock symbol (or ticker) of Adicet Bio Inc is ACET

How Can Investors Use Adicet Bio Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Adicet Bio Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Adicet Bio Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Adicet Bio Inc shares for Indian investors?

When investing in Adicet Bio Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Adicet Bio Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Adicet Bio Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Adicet Bio Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Adicet Bio Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top